Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma

被引：0
|
作者：
Yun Song
Richard J. Straker
Xiaowei Xu
David E. Elder
Phyllis A. Gimotty
Alexander C. Huang
Tara C. Mitchell
Ravi K. Amaravadi
Lynn M. Schuchter
Giorgos C. Karakousis
机构：
[1] University of Pennsylvania,Department of Surgery, Perelman School of Medicine
[2] University of Pennsylvania,Department of Pathology and Laboratory Medicine, Perelman School of Medicine
[3] University of Pennsylvania,Department of Biostatistics, Epidemiology, and Informatics
[4] University of Pennsylvania,Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine
[5] University of Pennsylvania,Parker Institute for Cancer Immunotherapy
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2915 / 2926
页数：11
相关论文
共 50 条
  • [1] Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma
    Song, Yun
    Straker, Richard J., III
    Xu, Xiaowei
    Elder, David E.
    Gimotty, Phyllis A.
    Huang, Alexander C.
    Mitchell, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Karakousis, Giorgos C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 2915 - 2926
  • [2] Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient
    Mandala, Mario
    Merelli, Barbara
    Indriolo, Amedeo
    Tondini, Carlo
    EUROPEAN JOURNAL OF CANCER, 2018, 95 : 130 - 132
  • [3] Overall Survival Comparing Neoadjuvant versus Adjuvant Alone Immunotherapy in Clinical Stage III Melanoma
    Dheer, Anushka
    Tortorello, Gabriella
    Shafique, Neha
    Mitchell, Tara
    Miura, John
    Karakousis, Giorgos
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S219 - S219
  • [4] Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
    Sarver, Melissa
    Brown, Michael C.
    Rhodin, Kristen E.
    Salama, April K. S.
    Beasley, Georgia M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
  • [5] Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
    Ferraresi, Virginia
    Vari, Sabrina
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
  • [6] Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches
    Tarhini, Ahmad A.
    Castellano, Ella
    Eljilany, Islam
    CANCER JOURNAL, 2024, 30 (02): : 54 - 70
  • [7] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Blank, Christian U.
    Rozeman, Elisa A.
    Fanchi, Lorenzo F.
    Sikorska, Karolina
    van de Wiel, Bart
    Kvistborg, Pia
    Krijgsman, Oscar
    van den Braber, Marlous
    Philips, Daisy
    Broeks, Annegien
    van Thienen, Johannes, V
    Mallo, Henk A.
    Adriaansz, Sandra
    ter Meulens, Sylvia
    Pronk, Loes M.
    Grijpink-Ongering, Lindsay G.
    Bruining, Annemarie
    Gittelman, Rachel M.
    Warren, Sarah
    van Tinteren, Harm
    Peeper, Daniel S.
    Haanen, John B. A. G.
    van Akkooi, Alexander C. J.
    Schumacher, Ton N.
    NATURE MEDICINE, 2018, 24 (11) : 1655 - +
  • [8] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Christian U. Blank
    Elisa A. Rozeman
    Lorenzo F. Fanchi
    Karolina Sikorska
    Bart van de Wiel
    Pia Kvistborg
    Oscar Krijgsman
    Marlous van den Braber
    Daisy Philips
    Annegien Broeks
    Johannes V. van Thienen
    Henk A. Mallo
    Sandra Adriaansz
    Sylvia ter Meulen
    Loes M. Pronk
    Lindsay G. Grijpink-Ongering
    Annemarie Bruining
    Rachel M. Gittelman
    Sarah Warren
    Harm van Tinteren
    Daniel S. Peeper
    John B. A. G. Haanen
    Alexander C. J. van Akkooi
    Ton N. Schumacher
    Nature Medicine, 2018, 24 : 1655 - 1661
  • [9] Opportunities for Discovery Using Neoadjuvant Immune Checkpoint Blockade in Melanoma
    Nair, Uma
    Rakestraw, Emily
    Beasley, Georgia M.
    O'Connor, Margaret H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [10] Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
    Herrscher, Hugo
    Robert, Caroline
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 106 - 113
12345